CMS Sends Cease and Desist Letters to 171 Clinical Laboratories Without Correct CLIA Certification
![CMS maze of rules and regulations](https://covid19briefings.com/wp-content/uploads/2020/05/AS_190179477-cl-SM-1024x699.jpg)
Rollout and availability of rapid SARS-CoV-2 antigen tests opens wave of CLIA certification issues triggering CMS cease and desist letters.
Rollout and availability of rapid SARS-CoV-2 antigen tests opens wave of CLIA certification issues triggering CMS cease and desist letters.